LSD

Ji Wîkîpediya, ensîklopediya azad.
Guhartoya 01:42, 13 sibat 2021 ya ji aliyê Dilovan Gervan (gotûbêj | beşdarî) (Bi rêya wergerandina rûpela "Lysergic acid diethylamide" hat çêkirin) ve
(cudahî) ← Guhartoya kevintir | Guhartoya niha (cudahî) | Guhartoya nûtir → (cudahî)
Lysergic acid diethylamide (LSD)
2D structural formula and 3D models of LSD
Systematic (IUPAC) name
(6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Clinical data
AHFS/Drugs.com Reference
Pregnancy cat. C (US)
Legal status Prohibited (S9) (AU) Schedule III (CA) Class A (UK) Schedule I (US) Psychotropic Schedule I (UN)
Dependence liability Low[1]
Routes By mouth, under the tongue, intravenous
Pharmacokinetic data
Bioavailability 71%[2]
Protein binding Unknown[3]
Metabolism Liver (CYP450)[2]
Half-life 3.6 hours[2][4]
Excretion Kidneys[2][4]
Identifiers
CAS number 50-37-3Şablon:Cascite
ATC code None
PubChem CID 5761
IUPHAR ligand 17
DrugBank DB04829
ChemSpider 5558Şablon:Chemspidercite
UNII 8NA5SWF92OŞablon:Fdacite
ChEBI CHEBI:6605 YesY
ChEMBL CHEMBL263881 YesY
Synonyms LSD, LSD-25, Acid, Delysid, others
PDB ligand ID 7LD (PDBe, RCSB PDB)
Chemical data
Formula Şablon:OrganicBox atomŞablon:OrganicBox atomŞablon:OrganicBox atomŞablon:OrganicBox atom 
  • CCN(CC)C(=O)[C@H]1CN([C@@H]2Cc3c[nH]c4c3c(ccc4)C2=C1)C
  • InChI=1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18-/m1/s1 YesY
    Key:VAYOSLLFUXYJDT-RDTXWAMCSA-N YesY

Physical data
Melt. point 80–85 °C (176–185 °F)
 YesY (what is this?)  (verify)

Diyet îla hdjdbdjbddjbdidbdidveinw jdhdhdjhdhdvd jd Jbv h here mîdê asîdê lîzergî ( LSD ), [a] ku bi devkî wekî asîd jî tê zanîn, dermanek hallucînojen e. Bandorên bi gelemperî raman, hest, û hay ji derdora xwe diguhezin. [5] Halusinasyonên dîtbarî an guhdarî yên gelek bikarhêneran hene. [6] [7] Pagirtên belavbûyî, zêdebûna tansiyonê, û zêdebûna germahiya laş tîpîk in. Bandorên bi gelemperî di nav nîv saet de dest pê dikin û dikarin heya 20 demjimêran bidomînin. [8] Ew bi giranî wekî dermanek rekreasyonê an ji ber


Jxjcjdbdid dhudd d dhsbdhd d djid chides sedemên giyanî tê bikar anîn. [9] [10]

Bandorên

Hin nîşanên ji bo LSD hatine ragihandin [11] [12]

Çavkanî

  1. ^ Halpern JH, Suzuki J, Huertas PE, Passie T (7 hezîran 2014). "Hallucinogen Abuse and Dependence". Bi Price LH, Stolerman IP (edîtor). Encyclopedia of Psychopharmacology A Springer Live Reference. Heidelberg, Germany: Springer-Verlag Berlin Heidelberg. rr. 1–5. doi:10.1007/978-3-642-27772-6_43-2. ISBN 978-3-642-27772-6. Hallucinogen abuse and dependence are known complications resulting from ... LSD and psilocybin. Users do not experience withdrawal symptoms, but the general criteria for substance abuse and dependence otherwise apply. Dependence is estimated in approximately 2 % of recent-onset users
  2. ^ a b c d Xeletiya çavkanî: Invalid <ref> tag; no text was provided for refs named Dol2015
  3. ^ Xeletiya çavkanî: Invalid <ref> tag; no text was provided for refs named Pas2008
  4. ^ a b Mucke HA (tîrmeh 2016). "From Psychiatry to Flower Power and Back Again: The Amazing Story of Lysergic Acid Diethylamide". Assay and Drug Development Technologies. 14 (5): 276–281. doi:10.1089/adt.2016.747. PMID 27392130.
  5. ^
  6. ^
  7. ^
  8. ^
  9. ^
  10. ^
  11. ^
  12. ^


Xeletiya çavkanî: <ref> tags exist for a group named "lower-alpha", but no corresponding <references group="lower-alpha"/> tag was found